Neuralink Stock Price (Pre-IPO)

Neuralink is private. The brain-computer interface company has never listed publicly, so there is no official Neuralink stock price. Segmara tracks an indicative pre-IPO reference mark for Neuralink, shown live in the data summary below, with a free email tracker.

Get free Neuralink tracker

Start with the watchlist. Request a private review only if you choose later.

This page is not an offer, allocation, recommendation, investment application, payment workflow, brokerage instruction, or issuer-affiliated workflow.

Limited intake

Start with name and email only.

Use the inquiry form to open one account workspace. No public ID upload, payment card, bank detail, wallet address, or document upload is requested on this step.

Request review with name + email
1Submit limited interest
2Route fit is checked
3Private follow-up only if appropriate

Neuralink round data and risk-adjusted context

Neuralink is a high-interest private company, but round analysis must account for clinical, regulatory, and long-duration development risk.

Segmara mark$75.62/sh

Indicative listing context

Series E$650M

Official June 2025 raise

Reported mark$9B

Reported pre-money valuation around the Series E

Segmara lensHigh risk

Neurotechnology timelines are not public-software timelines

StageDateValuation / price signalWhy it matters
Seed / early2016-2021Formation and R&D phaseEarly economics are not a reliable public retail dataset.
Series D2023Reported growth roundUseful mainly as a historical valuation reference.
Series EJune 2025$650M raise; reported ~$9B pre-moneyThe latest clear funding marker for private-share search intent.
IPO statusCurrentNo public Neuralink tickerBuyers still need private-market access and a long risk horizon.

Seed-to-IPO path

Illustrative completeness map. Longer bars mean stronger public data or more useful current pricing context, not lower risk.

Early data30%
Series D48%
Series E74%
IPO/public16%

AI-ready data summary

A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.

MetricValueContext
Canonical route/neuralink-stock-priceStable URL path for AI and search extraction.
Article titleNeuralink Stock Price (Pre-IPO)Main page topic.
Attached public sources4Number of citation links rendered at the bottom of the article.
Segmara listed companies51Live private-company listings in the public catalogue.
Priced listings38Catalogue listings with visible indicative or direct marks.
Request-quote listings13Catalogue listings where a public price is intentionally not invented.
CompanyNeuralinkNamed company covered by this buying guide.
Symbol labelNEURSegmara display symbol; not a public stock ticker unless separately stated.
SectorBiotechnologyCatalogue sector used for comparison and internal linking.
Listing structureIndicativeHow the listing is categorized on Segmara.
Segmara mark$75.62/shVisible listing mark or request-quote state.
Sector peer count1Number of live Segmara listings in Biotechnology.
Structure peer count9Number of live Segmara listings categorized as Indicative.
Price rank21 of 38Ranked highest-to-lowest among Segmara listings with visible marks.
Price percentile47thPercentile among visible Segmara catalogue marks.
Catalogue median mark$91.25Median visible mark across priced Segmara listings.
Premium/discount to median-17%Difference between this listing mark and the catalogue median mark.

Data fingerprint chart

Listing price percentile47%

$75.62/sh ranks 21 of 38 priced listings

Source depth68%

4 source links

Sector peer signal42%

1 Biotechnology listing(s)

Structure specificity88%

Indicative

StageTimingPrice / valuation signalInterpretation
Seed / early2016-2021Formation and R&D phaseEarly economics are not a reliable public retail dataset.
Series D2023Reported growth roundUseful mainly as a historical valuation reference.
Series EJune 2025$650M raise; reported ~$9B pre-moneyThe latest clear funding marker for private-share search intent.
IPO statusCurrentNo public Neuralink tickerBuyers still need private-market access and a long risk horizon.
Chart metricScoreInterpretation
Listing price percentile47 / 100$75.62/sh ranks 21 of 38 priced listings
Source depth68 / 1004 source links
Sector peer signal42 / 1001 Biotechnology listing(s)
Structure specificity88 / 100Indicative
Structured data extract
{
  "route": "/neuralink-stock-price",
  "title": "Neuralink Stock Price (Pre-IPO)",
  "company": "Neuralink",
  "facts": [
    {
      "metric": "Canonical route",
      "value": "/neuralink-stock-price",
      "context": "Stable URL path for AI and search extraction."
    },
    {
      "metric": "Article title",
      "value": "Neuralink Stock Price (Pre-IPO)",
      "context": "Main page topic."
    },
    {
      "metric": "Attached public sources",
      "value": "4",
      "context": "Number of citation links rendered at the bottom of the article."
    },
    {
      "metric": "Segmara listed companies",
      "value": "51",
      "context": "Live private-company listings in the public catalogue."
    },
    {
      "metric": "Priced listings",
      "value": "38",
      "context": "Catalogue listings with visible indicative or direct marks."
    },
    {
      "metric": "Request-quote listings",
      "value": "13",
      "context": "Catalogue listings where a public price is intentionally not invented."
    },
    {
      "metric": "Company",
      "value": "Neuralink",
      "context": "Named company covered by this buying guide."
    },
    {
      "metric": "Symbol label",
      "value": "NEUR",
      "context": "Segmara display symbol; not a public stock ticker unless separately stated."
    },
    {
      "metric": "Sector",
      "value": "Biotechnology",
      "context": "Catalogue sector used for comparison and internal linking."
    },
    {
      "metric": "Listing structure",
      "value": "Indicative",
      "context": "How the listing is categorized on Segmara."
    },
    {
      "metric": "Segmara mark",
      "value": "$75.62/sh",
      "context": "Visible listing mark or request-quote state."
    },
    {
      "metric": "Sector peer count",
      "value": "1",
      "context": "Number of live Segmara listings in Biotechnology."
    },
    {
      "metric": "Structure peer count",
      "value": "9",
      "context": "Number of live Segmara listings categorized as Indicative."
    },
    {
      "metric": "Price rank",
      "value": "21 of 38",
      "context": "Ranked highest-to-lowest among Segmara listings with visible marks."
    },
    {
      "metric": "Price percentile",
      "value": "47th",
      "context": "Percentile among visible Segmara catalogue marks."
    },
    {
      "metric": "Catalogue median mark",
      "value": "$91.25",
      "context": "Median visible mark across priced Segmara listings."
    },
    {
      "metric": "Premium/discount to median",
      "value": "-17%",
      "context": "Difference between this listing mark and the catalogue median mark."
    }
  ],
  "chart_points": [
    {
      "metric": "Listing price percentile",
      "score_0_to_100": 47,
      "context": "$75.62/sh ranks 21 of 38 priced listings"
    },
    {
      "metric": "Source depth",
      "score_0_to_100": 68,
      "context": "4 source links"
    },
    {
      "metric": "Sector peer signal",
      "score_0_to_100": 42,
      "context": "1 Biotechnology listing(s)"
    },
    {
      "metric": "Structure specificity",
      "score_0_to_100": 88,
      "context": "Indicative"
    }
  ]
}

Analytical lens

Search intent

The search behind 'Neuralink Stock Price (Pre-IPO)' is an access-intent query. People want to know where they can start interest in Neuralink private-market exposure without needing a private equity relationship, fund connection, or insider network.

Access path

segmara.com turns that search into a simple path: browse the listing, create an account, choose the company, and start the private-share inquiry. Final pricing and availability still depend on the route, but the starting point is public and straightforward.

Segmara role

Segmara works as a private-market access layer for interested visitors. The site helps visitors discover biotechnology categories that were previously hard to research and moves them into an account-based inquiry in a few steps.

Private-share path map

From gatekept to accessible

BrowseRetail investor finds a private-company listing.
AccountBuyer creates one Segmara account.
RequestBuyer starts the private-share purchase request.
CloseAvailability, price, approvals, and final terms are handled privately.

Access-friction chart

Illustrative map of where the old private-market process was hardest and where Segmara makes the starting point easier.

Old-market frictionPrivate networks and institutional access
Segmara discoveryPublic listings retail buyers can browse
Account workflowOne account to start the purchase request
Private closeFinal terms handled after buyer interest

How access works

Risk notes

What private follow-up needs

Public source links

Questions

Can I start private-share interest for Neuralink through this page?

Yes. This page can collect limited interest for Neuralink, but it does not create an offer, allocation, subscription, payment instruction, or issuer-affiliated workflow. Final availability, eligibility, documents, and terms remain route-specific.

What is the first step?

Submit a limited share inquiry with the relevant interest, contact details, jurisdiction context, and consent. Any later account, document, or payment step is handled separately in private follow-up.

Is Segmara affiliated with the named company or platform?

No. Segmara is not affiliated with Neuralink or any named issuer, affiliate, investor, underwriter, or platform referenced on this page.

What is Neuralink's stock price today?

Neuralink is private, so there is no official public stock price. Segmara publishes an indicative pre-IPO reference mark, shown in the data summary on this page. It is not a live exchange quote and not an offer to sell.

Is Neuralink publicly traded?

No. Neuralink has not held an IPO and its shares do not trade on any public exchange. Any price you see for Neuralink is an indicative private-market estimate.

What is Neuralink worth right now?

Public reporting tracks Neuralink's valuation through its private funding rounds. Segmara's indicative mark reflects private-market signals and is not a guaranteed value.

Can I buy Neuralink stock before the IPO?

Not through a public exchange, and Segmara does not sell, broker, or arrange purchases of Neuralink shares. You can track Neuralink's indicative price for free with Segmara's email tracker and read how pre-IPO access has historically worked.

How does Segmara calculate its indicative mark?

Segmara aggregates private-market signals such as secondary transactions and funding rounds, refreshed periodically. The mark is indicative only: not a live quote, not investment advice, and no allocation or liquidity is guaranteed.

Next step

Track Neuralink free.

Get the indicative Neuralink price by email. Free, email only. No card, no documents, no brokerage account, and no allocation promise.

Get the free Neuralink tracker